Project Grant HT94252510646
Award Date
9/15/25
Completion Date
9/14/27
Dollars Obligated
$250K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
This $1,354,428 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a family-centered e-health intervention to promote patient and caregiver well-being in adolescent and emerging adult pediatric brain tumor survivors. The grant was awarded to the Children's Hospital Medical Center in Cincinnati, Ohio, which will serve as the prime awardee. The project duration is from September 1, 2024 to August 31, 2028. The...
The Defense Health Agency awarded a $1,528,727.00 Project Grant to Children's Research Institute, a subsidiary of Children's National Medical Center, to develop SGT-53, a novel nanomedicine that crosses the blood-brain barrier and augments immunotherapeutic response in pediatric brain cancers. This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the...
This $1,000,000 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) program will support advanced biomedical research by the Childrens Hospital Medical Center in Cincinnati, Ohio. The grant, with a performance period from September 1, 2024 to August 31, 2028, will fund research focused on "Follicular T-Cell Targeting in Therapy of Lupus". As a leading pediatric hospital and research institution, Childrens...
The Defense Health Agency awarded a $1,249,009 Project Grant to the Research Institute at Nationwide Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on August 15, 2023, funds a 4-year project titled "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA" to conduct medical research and development related to improving treatments for glioma, a type of brain cancer. As a non-profit research institute, the...
The Project Grant award of $624,000 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program to the Research Institute at Nationwide Children's Hospital. The funding supports a project titled "SPLICING UP PD-L1 FOR IMMUNOTHERAPY ENHANCEMENT IN PEDIATRIC NEURONAL TUMORS" over a two-year period from September 30, 2023 to September 29, 2025. The goal is to conduct research to advance immunotherapy approaches...
The federal Project Grant award of $624,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award, with a performance period from September 1, 2025, to August 31, 2027, will fund a comprehensive in vivo phenotyping study of fusion-driven pediatric rhabdomyosarcomas conducted by the...
This $152,761 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a research study at The Children's Hospital of Philadelphia (CHOP) investigating the use of quantitative sodium magnetic resonance imaging (MRI) and chemical exchange saturation transfer (CEST) to analyze low-grade gliomas in children with neurofibromatosis type 1. The 2-year study, which commenced on September 15, 2023, aims to advance diagnostic...
This federal Project Grant award of $1,317,452.00 from the Defense Health Agency (DHA) was provided to the Research Institute at Nationwide Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 4-year research project titled "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA" that commenced on August 15, 2023 and is scheduled for completion by August 14, 2027. The Research Institute at Nationwide Children's...
This Project Grant award for $616,710.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the Children's Research Institute in Washington, D.C. in designing effective adoptive immunotherapy for high-risk pediatric medulloblastoma. The research aims to develop a rational combination with MRI-guided focused ultrasound technology to enhance this innovative cancer treatment approach. The award period runs from August 1, 2024...
The Defense Health Agency awarded a $997,343 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a multidimensional imaging data-driven approach for phenotyping multiple sclerosis. The research aims to transform healthcare for military service members and the broader public through innovative and impactful biomedical investigations spanning basic, applied, and translational research. The award period runs from...